ClinicalTrials.gov
ClinicalTrials.gov Menu

Panretinal Photocoagulation for Proliferative Diabetic Retinopathy in a Single Session Using Low Fluence Parameters (PFC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01023698
Recruitment Status : Unknown
Verified December 2009 by Asociación para Evitar la Ceguera en México.
Recruitment status was:  Enrolling by invitation
First Posted : December 2, 2009
Last Update Posted : December 2, 2009
Sponsor:
Information provided by:
Asociación para Evitar la Ceguera en México

Brief Summary:
Is it possible to do a panretinal photocoagulation for proliferative diabetic retinopathy in a single session using low fluence parameters?

Condition or disease Intervention/treatment Phase
Neovascular Procedure: laser photocoagulation Phase 4

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 30 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Panretinal Photocoagulation for Proliferative Diabetic Retinopathy in a Single Session Using Low Fluence Parameters
Study Start Date : April 2009
Estimated Primary Completion Date : April 2010
Estimated Study Completion Date : April 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: photocoagulation
Laser photocoagulation
Procedure: laser photocoagulation
Laser photocoagulation



Primary Outcome Measures :
  1. Stabilization of proliferative diabetic retinopathy [ Time Frame: 2010 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • untreated Proliferative diabetic retinopathy

Exclusion Criteria:

  • Previous photocoagulation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01023698


Sponsors and Collaborators
Asociación para Evitar la Ceguera en México
Investigators
Principal Investigator: Maria A Martinez-Castellanos, MD Asociacion para Evitar la Ceguera en México

Responsible Party: Maria Ana Martínez Castellanos MD, Asociación para Evitar la Ceguera en México
ClinicalTrials.gov Identifier: NCT01023698     History of Changes
Other Study ID Numbers: APEC0003
First Posted: December 2, 2009    Key Record Dates
Last Update Posted: December 2, 2009
Last Verified: December 2009

Keywords provided by Asociación para Evitar la Ceguera en México:
Diabetic retinopathy
Diabetic macular edema
Panretinal photocoagulation

Additional relevant MeSH terms:
Retinal Diseases
Diabetic Retinopathy
Eye Diseases
Diabetic Angiopathies
Vascular Diseases
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases